Skip to Content

Overall survival in patients with advanced stage Hodgkin’s Lymphoma improves on Brentuximab Vedotin

Brentuximab Vedotin plus chemotherapy as first-line treatment improves the overall survival in patients suffering from stage III or IV Hodgkin’s Lymphoma. Get an update on the ECHELON-1 trial by investigator Stephen Ansell in this MEDtalk.

Stephen Ansell

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top